A recent article in the BMJ highlighted concerns about the statin Crestor which in 2014 was the most prescribed brand name drug in the US, with 22.3 million prescriptions at a cost of $5.8bn. World-wide sales for 2013 were...Read More
- 306. Opioids
- 305. A Comparison between the approaches to Type 2 Diabetes (T2D) by Dr David Unwin and Diabetes UK
- 304. Sulphonylureas increase cardiac deaths but are still recommended for use after Metformin in type two diabetics in Scotland.
- 303. Statins: Why it is crucial to have a comprehensive picture
- 302. The Conventional Treatment of Type 2 Diabetes (T2D)